{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2.9","upperLimit":"131.7","value":"25.7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"164"}],"units":"Participants"}],"description":"GTV is the volume of the tumor determined by imaging used for radiation treatment planning. The study protocol indicates that participants are analyzed as a single group, treatment arms combined. Correlation of Baseline Log HPV DNA Copy Number and Gross Tumor Volume (GTV) are reported in another outcome measure.","dispersionType":"Full Range","groups":[{"description":"IMRT 6 Weeks + Cisplatin arm: Cisplatin: 40 mg/m2 IV (intravenously) weekly for 6 weeks; Intensity-modulated radiation therapy (IMRT), 30 fractions over 6 weeks, 5 fractions per week, 2 Gray per fraction to total dose of 60 Gy.\n\nIMRT 5 weeks arm: Intensity-modulated radiation therapy (IMRT), 30 fractions over 5 weeks, 6 fractions per week, 2 Gray per fraction to total dose of 60 Gy","id":"OG000","title":"Both Arms Combined"}],"paramType":"MEDIAN","populationDescription":"Eligible participants with baseline HPV DNA value","reportingStatus":"POSTED","timeFrame":"Baseline","title":"Gross Tumor Volume (GTV) [for Purpose of Correlation]","type":"SECONDARY","unitOfMeasure":"mL"}